Literature DB >> 34389559

A. Muciniphila Suppresses Colorectal Tumorigenesis by Inducing TLR2/NLRP3-Mediated M1-Like TAMs.

Lina Fan1,2, Chaochao Xu2,3, Qiwei Ge1,2, Yifeng Lin1,2, Chi Chun Wong4,5, Yadong Qi2,3, Bin Ye6, Qingwu Lian6, Wei Zhuo2,7, Jianmin Si8,3,9, Shujie Chen8,3,9, Liangjing Wang10,2,9.   

Abstract

The interplay between gut microbiota and the host immune system is emerging as a factor in the pathogenesis of colorectal cancer. Here, we set out to identify the effect of Akkermansia muciniphila (A. muciniphila) on colorectal cancer pathogenesis. A. muciniphila abundance was significantly reduced in patients with colorectal cancer from two independent clinical cohorts and the GMrepo dataset. Supplementation with A. muciniphila suppressed colonic tumorigenesis in ApcMin/+ mice and the growth of implanted HCT116 or CT26 tumors in nude mice. Mechanistically, A. muciniphila facilitated enrichment of M1-like macrophages in an NLRP3-dependent manner in vivo and in vitro. As a consequence, NLRP3 deficiency in macrophages attenuated the tumor-suppressive effect of A. muciniphila. In addition, we revealed that TLR2 was essential for the activation of the NF-κB/NLRP3 pathway and A. muciniphila induced M1-like macrophage response. We observed positive correlations between M1-like macrophages, NLRP3/TLR2 and A. muciniphila in patients with colorectal cancer, which corroborated these findings. In summary, A. muciniphila-induced M1-like macrophages provide a therapeutic target in the colorectal cancer tumor microenvironment. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34389559     DOI: 10.1158/2326-6066.CIR-20-1019

Source DB:  PubMed          Journal:  Cancer Immunol Res        ISSN: 2326-6066            Impact factor:   11.151


  7 in total

Review 1.  The role of NLRP3 inflammasome in colorectal cancer: potential therapeutic target.

Authors:  Somayeh Vafaei; Hamed Taheri; Yasamin Hajimomeni; Amirhossein Fakhre Yaseri; Firoozeh Abolhasani Zadeh
Journal:  Clin Transl Oncol       Date:  2022-06-10       Impact factor: 3.340

2.  Suppression of Berberine and Probiotics (in vitro and in vivo) on the Growth of Colon Cancer With Modulation of Gut Microbiota and Butyrate Production.

Authors:  Chao Huang; Ying Sun; Sheng-Rong Liao; Zhao-Xin Chen; Han-Feng Lin; Wei-Zeng Shen
Journal:  Front Microbiol       Date:  2022-04-28       Impact factor: 6.064

3.  Fusobacterium nucleatum promotes colorectal cancer cells adhesion to endothelial cells and facilitates extravasation and metastasis by inducing ALPK1/NF-κB/ICAM1 axis.

Authors:  Ying Zhang; Lu Zhang; Sheng Zheng; Mengjie Li; Chaochao Xu; Dingjiacheng Jia; Yadong Qi; Tongyao Hou; Lan Wang; Boya Wang; Aiqing Li; Shujie Chen; Jianmin Si; Wei Zhuo
Journal:  Gut Microbes       Date:  2022 Jan-Dec

4.  Interaction Between Macrophage Extracellular Traps and Colon Cancer Cells Promotes Colon Cancer Invasion and Correlates With Unfavorable Prognosis.

Authors:  Tianli Chen; Yue Wang; Zhaodi Nan; Jie Wu; Ailu Li; Tingguo Zhang; Xun Qu; Chen Li
Journal:  Front Immunol       Date:  2021-12-01       Impact factor: 7.561

5.  Evaluating the role of IDO1 macrophages in immunotherapy using scRNA-seq and bulk-seq in colorectal cancer.

Authors:  Xingwu Liu; Guanyu Yan; Boyang Xu; Han Yu; Yue An; Mingjun Sun
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

6.  Focus on pattern recognition receptors to identify prognosis and immune microenvironment in colon cancer.

Authors:  Pengtao Ren; Yuan Zhang
Journal:  Front Oncol       Date:  2022-09-23       Impact factor: 5.738

Review 7.  Native and Engineered Probiotics: Promising Agents against Related Systemic and Intestinal Diseases.

Authors:  Haokun Shen; Zitong Zhao; Zengjue Zhao; Yuyi Chen; Linghua Zhang
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.